No Prescription |
 |
 | ||
|
Beta Generic Betamethasone Valerate |
|
| ||
No Prescription » Prescription Drugs 3 » Beta Generic Betamethasone Valerate BETA CREAM or OINTMENT contains the active ingredient betamethasone valerate. It belongs to a group of medicines known as topical corticosteroids. "Topical" means that they are applied onto the skin. Topical steroids are used to help reduce inflammation in the affected area which helps to reduce redness and itchiness caused by the skin disease. BETA CREAM or OINTMENT is useful in treating various inflamed conditions of the skin such as:psoriasis severe forms of eczema lichen planus (chronic itchy skin of unknown origin) discoid lupus erythematosus (recurring scaly rash) when milder topical steroids cannot treat the skin condition effectively. BETA CREAM is used to treat skin conditions on moist surfaces; BETA OINTMENT is used to treat skin conditions on dry scaly skin.Your doctor however may prescribe BETA CREAM or OINTMENT for another purpose. Ask your doctor if you have any questions about why BETA CREAM or OINTMENT has been prescribed for you.There is no evidence that BETA CREAM or OINTMENT is addictive. Buy Beta Generic Betamethasone Valerate and other Prescription Drugs 3 products online at Medstore. Buy Online at Medstore - Click Here!
About Beta Generic Betamethasone Valerate: Product Type: Prescription Drugs 3 Beta ( Generic Betamethasone Valerate ) Beta (Generic Betamethasone Valerate) Generic Betamethasone Valerate 0.1%w/w Cream 50gm 0.1%w/w Ointment Generic Betamethasone Valerate Beta
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
